We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

JYD:NASDAQJayud Global Logistics Limited Analysis

Data as of 2026-04-12 - not real-time

$2.98

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Jayud Global Logistics (JYD) is trading at $2.98, just above its 20‑day ($2.93) and 50‑day ($2.81) simple moving averages but far below the 200‑day SMA ($5.61), indicating a short‑term bias with a longer‑term downtrend. Technicals show a modest bullish MACD crossover and a neutral RSI (53.9), while volume is on a decreasing trend and 30‑day volatility spikes at 59%, reflecting a choppy price environment. Fundamentally, the company is in distress: it reports negative profit margins (‑5.2%), a loss of $33.8 M EBITDA, negative operating and free cash flow, and a staggering max drawdown of ‑87%. However, valuation multiples are ultra‑low (price‑to‑book 0.42, price‑to‑sales 0.014) and a recent $6.7 M registered direct offering at $1.34 per share has added cash to the balance sheet.
The stock’s market cap is only $8.1 M with thin, decreasing trading volume, a beta near 2.9 and high sector exposure to China’s logistics landscape, all of which amplify market, geographic and regulatory risks. Given the mix of technical modest upside potential but severe fundamental weakness, investors should approach JYD with caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD crossover suggests limited upside
  • Recent $6.7 M capital raise improves short‑term cash position
  • Price sits near support ($2.67) and resistance ($3.05) levels

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Persistent operating losses and negative cash flow
  • High volatility and beta indicating price sensitivity
  • Low valuation multiples may attract value seekers but risk remains

Long Term

> 3 years
Cautious
Model confidence: 3/10

Key Factors

  • Continued earnings deficits and weak profitability
  • Exposure to China‑specific regulatory and economic headwinds
  • Thin market capitalization and decreasing liquidity

Key Metrics & Analysis

Financial Health

Revenue Growth3.70%
Profit Margin-5.19%
ROE-188.00%
ROA-15.32%
Debt/Equity25.88
P/B Ratio0.4
Op. Cash Flow$-83899240
Free Cash Flow$-63656996
Industry P/E30.9

Technical Analysis

TrendNeutral
RSI54.0
Support$2.67
Resistance$3.05
MA 20$2.93
MA 50$2.81
MA 200$5.61
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta2.85
Volatility59.46%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.